EUVIMEDPoznaj EUVIMED
Crossref

Nomograms for Prediction of High‐Volume Lymph Node Metastasis in Papillary Thyroid Carcinoma Patients

Jia-Wei Feng, Jing Ye, Gao-Feng Qi, Li-Zhao Hong, Jun Hu, Fei Wang, Sheng-Yong Liu, Yong Jiang iD

Otolaryngology–Head and Neck Surgery · 2023

DOI: 10.1002/ohn.161 ↗

At a glance

Journal article in Otolaryngology–Head and Neck Surgery, 2023. Written by Jia-Wei Feng and 7 co-authors. Institution: Department of Thyroid Surgery, The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, Jiangsu, China. Major MEDLINE topics: Thyroid Neoplasms, Carcinoma, Papillary. Cited 5 times so far (Crossref); 39 references.

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Objective

The coexistence rate between chronic lymphocytic thyroiditis (CLT) and papillary thyroid carcinoma (PTC) is quite high. Whether CLT influences metastatic lymph nodes remains uncertain. High‐volume lymph node metastasis is recommended as an unfavorable pathological feature. We aimed to investigate risk factors for high‐volume central lymph node metastasis (CLNM) and lateral lymph node metastasis (LLNM) in PTC patients. Study Design Retrospective cohort study.

Setting

Changzhou First People's Hospital.

Methods

Clinicopathological characteristics of 1094 PTC patients who underwent surgery in our center from January 2019 to November 2021 were analyzed.

Results

The number of metastatic lymph nodes in the central compartment and lateral compartment were lower in the CLT group. We demonstrated that age, BRAF V600E, shape, and the number of foci were risk factors for high‐volume CLNM in patients with CLT. For patients without CLT, sex, age, tumor size, number of foci, and margin were risk factors for high‐volume CLNM. Tumor size, number of foci, location, and CLNM were all risk factors for high‐volume LLNM in patients with or without CLT. Body mass index was only associated with high‐volume LLNM in CLT patients. All the above factors were incorporated into nomograms, which showed perfect discriminative ability.

Conclusion

Separate predictive systems should be used for CLT and non‐CLT patients for a more accurate clinical assessment of lymph node status. Our nomograms of predicting high‐volume CLNM and LLNM could facilitate risk‐stratified management of PTC recurrence and treatment decisions.

Subjects

MeSH terms (MEDLINE)

Thyroid NeoplasmsCarcinoma, PapillaryHumansThyroid Cancer, PapillaryNomogramsRetrospective StudiesLymphatic MetastasisLymph NodesRisk Factors

Author keywords

central lymph node metastasischronic lymphocytic thyroiditislateral lymph node metastasisnomogrampapillary thyroid carcinoma

Authors and institutions

  • Department of Thyroid Surgery, The Third Affiliated Hospital of Soochow University, Changzhou First People's Hospital, Changzhou, Jiangsu, China.

ORCID profiles: Yong Jiang

Cite

APA

Feng, J. W., Ye, J., Qi, G. F., Hong, L. Z., Hu, J., Wang, F., Liu, S. Y., & Jiang, Y. (2023). Nomograms for Prediction of High‐Volume Lymph Node Metastasis in Papillary Thyroid Carcinoma Patients. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.161

Vancouver

Feng JW, Ye J, Qi GF, Hong LZ, Hu J, Wang F, et al. Nomograms for Prediction of High‐Volume Lymph Node Metastasis in Papillary Thyroid Carcinoma Patients. Otolaryngology–Head and Neck Surgery. 2023. doi:10.1002/ohn.161

BibTeX
@article{Feng2023,
  author = {Feng, Jia-Wei and Ye, Jing and Qi, Gao-Feng and Hong, Li-Zhao and Hu, Jun and Wang, Fei and Liu, Sheng-Yong and Jiang, Yong},
  title = {Nomograms for Prediction of High‐Volume Lymph Node Metastasis in Papillary Thyroid Carcinoma Patients},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2023},
  doi = {10.1002/ohn.161}
}
Start for free →